Archive | TB RSS feed for this section

Technical Brief: Strategic Purchasing Approaches for the Tuberculosis Hospital System in Ukraine

Resource Type: Technical Brief Authors: Olga Zues, Alexandr Katsaga, Sara Feinstein, Barton Smith, and Sarah Dominis Published: September 2018 Resource Description: The Health Finance and Governance Project (HFG), funded by the United States Agency for International Development-funded (USAID), worked closely with national and regional partners to develop strategic purchasing approaches for TB hospitals in the country and […]

South Africa HIV and TB Expenditure Review (2014/15 – 2016/17)

Resource Type: Expenditure Review Authors: Guthrie T, Chaitkin M, Khoza N, Zulu N, Madisha V, Ndlovu N, Shezi S, Karume J, Motsoeneng P, Simelane S, Meyer-Rath G, Masuku S, Jamieson L, and Ghai K. Published: August 2018 Resource Description: The South African Government (SAG) and its development partners have mounted a formidable response to the world’s largest HIV epidemic […]

Integrating Financing of Vertical Health Programs: Lessons from Kyrgyzstan and the Philippines

Resource Type: Publication Authors: Health Finance and Governance Project Published: September 2018 Resource Description: For better or worse, many low- and middle- income countries inherited vertical programs in which programming, financing, governance, and service delivery are all organized around an individual disease.  Governments must now decide whether a new government-managed financing scheme such as national or social health […]

Spending Wisely for Improved TB Outcomes: Lessons in Strategic Purchasing for TB in Eastern Europe and Central Asia

Resource Type: Brief Authors: Dasha Migunov, Sara Feinstein, Sevim Ahmedov, Olga Zues and Alexandr Katsaga Published: September 2018 Resource Description: The report’s objectives are to: Explain the importance of strategic purchasing for improving TB services in the Eastern Europe and Central Asia region, specifically through the examples presented at the May 2018 Spending Money Wisely for Improved […]

Supplementary Actuarial Analysis of Tuberculosis, LAGOS STATE, NIGERIA HEALTH SCHEME

Resource Type: Report Published: August 2018 Resource Description:Our focus in this report is to actuarially estimate the medical cost of including tuberculosis (TB) in the total benefit structure. We have considered modular pricing under 3 different regimens: Regimen I – Drug susceptible TB cases of Kids (pediatrics) Regimen II – Drug susceptible TB cases of adults Regimen […]

Case Study: The Dialogue on HIV and Tuberculosis Project, Kazakhstan

Resource Type: Case Study Authors: Adam Koon Published: June 2017 Resource Description: This report presents one of the five case studies – on the Dialogue Project on HIV/AIDS and Tuberculosis in Kazakhstan. In Section 2, we describe the study methods. In Section 3, we present the contours of the context in which the intervention was implemented, basic […]

Opportunities and Challenges to Develop Effective Strategies for Private Sector Engagement to end Tuberculosis in India

Resource Type: Publication Authors:  Amaltas Consulting Published: August 2017 Resource Description: This study undertakes a Political Economy Analysis (PEA) of the participation of private health care providers in tuberculosis care in four states (Bihar, Gujarat, Maharashtra, and West Bengal) in India to improve understanding of how their involvement in the national program could be enhanced. In […]

Health Officials from 10 countries in Europe and Central Asia meet on TB Financing

From May 28- 30, HFG held a workshop, “Spending Money Wisely for Improved Tuberculosis Outcomes,” in Bishkek, Kyrgyzstan.  Participants included representatives from ministries of health and health insurance funds from Armenia, Azerbaijan, Moldova, Belarus, Georgia, Uzbekistan, Tajikistan, Ukraine, Kazakhstan, and the Kyrgyz Republic. HFG presented results from Ukraine, where, in collaboration with the Ukraine Ministry of […]


Kyrgyzstan Modernizes TB Hospital Financing

The Kyrgyz Republic, a former Soviet Union country bordering China, has one of the highest rates of the difficult-to-treat multidrug resistant (MDR) tuberculosis in the world—with 26 percent of new TB cases estimated to be MDR, compared to 3 percent of new TB cases worldwide. According to the World Health Organization (WHO), only 55 percent […]

Back to Top